1. Home
  2. PEPG vs ATNI Comparison

PEPG vs ATNI Comparison

Compare PEPG & ATNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEPG
  • ATNI
  • Stock Information
  • Founded
  • PEPG 2018
  • ATNI 1987
  • Country
  • PEPG United States
  • ATNI United States
  • Employees
  • PEPG N/A
  • ATNI N/A
  • Industry
  • PEPG Biotechnology: Pharmaceutical Preparations
  • ATNI Telecommunications Equipment
  • Sector
  • PEPG Health Care
  • ATNI Telecommunications
  • Exchange
  • PEPG Nasdaq
  • ATNI Nasdaq
  • Market Cap
  • PEPG 317.6M
  • ATNI 254.3M
  • IPO Year
  • PEPG 2022
  • ATNI 1991
  • Fundamental
  • Price
  • PEPG $4.62
  • ATNI $14.18
  • Analyst Decision
  • PEPG Strong Buy
  • ATNI Strong Buy
  • Analyst Count
  • PEPG 6
  • ATNI 1
  • Target Price
  • PEPG $8.17
  • ATNI $30.00
  • AVG Volume (30 Days)
  • PEPG 9.6M
  • ATNI 31.9K
  • Earning Date
  • PEPG 11-06-2025
  • ATNI 10-28-2025
  • Dividend Yield
  • PEPG N/A
  • ATNI 7.76%
  • EPS Growth
  • PEPG N/A
  • ATNI N/A
  • EPS
  • PEPG N/A
  • ATNI N/A
  • Revenue
  • PEPG N/A
  • ATNI $719,593,000.00
  • Revenue This Year
  • PEPG N/A
  • ATNI $1.60
  • Revenue Next Year
  • PEPG N/A
  • ATNI $2.06
  • P/E Ratio
  • PEPG N/A
  • ATNI N/A
  • Revenue Growth
  • PEPG N/A
  • ATNI N/A
  • 52 Week Low
  • PEPG $0.88
  • ATNI $13.76
  • 52 Week High
  • PEPG $9.37
  • ATNI $33.72
  • Technical
  • Relative Strength Index (RSI)
  • PEPG 63.02
  • ATNI 36.12
  • Support Level
  • PEPG $4.70
  • ATNI $14.27
  • Resistance Level
  • PEPG $5.20
  • ATNI $15.35
  • Average True Range (ATR)
  • PEPG 0.56
  • ATNI 0.58
  • MACD
  • PEPG 0.00
  • ATNI -0.08
  • Stochastic Oscillator
  • PEPG 59.00
  • ATNI 11.00

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

About ATNI ATN International Inc.

ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.

Share on Social Networks: